Outbreak of varicella at a day-care center despite vaccination

New England Journal of Medicine

Volumn 347, Issue 24, 2002, Pages 1909-1915

  Galil, Karin ^a,d   Lee, Brent ^a   Strine, Tara ^a   Carraher, Claire ^b   Baughman, Andrew L ^a   Eaton, Melinda ^c   Montero, Jose ^b   Seward, Jane ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b New Hamsphire Department of Health   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ANALYSIS; ARTICLE; BUILDING; CHICKENPOX; CHILD; CONTROLLED STUDY; DAY CARE; DISEASE SEVERITY; EPIDEMIC; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTECTION; QUESTIONNAIRE; RISK FACTOR; SCHOOL CHILD; VACCINATION;

ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; NEW HAMPSHIRE; QUESTIONNAIRES; RISK FACTORS; TREATMENT FAILURE;

EID: 0037069786     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa021662     Document Type: Article

References (25)

1. Izurieta HS, Strebel PM, Blake PA. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA 1997;278:1495-9.
2. Buchholz U, Moolenaar R, Peterson C, Mascola L. Varicella outbreaks after vaccine licensure: Should they make you chicken? Pediatrics 1999;104: 561-3.
3. Clements DA, Moreira SP, Coplan PM, Bland CL, Walter EB. Postlicensure study of varicella vaccine effectiveness in a day-care setting. Pediatr Infect Dis J 1999;18:1047-50.
4. Vázquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 2001;344:955-60.
5. Galil K, Fair E, Mountcastle N, Britz P, Seward J. Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis 2002;186: 102-5.
6. Dworkin MS, Jennings CE, Roth-Thomas J, Lang JE, Stukenberg C, Lumpkin JR. An outbreak of varicella among children attending preschool and elementary school in Illinois. Clin Infect Dis 2002;35:102-4.
7. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine: Efficacy trial in healthy children. N Engl J Med 1984;310:1409-15.
8. Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics 1986;78:748-56.
9. Johnson CE, Shurin PA, Fattlar D, Rome LP, Kumar ML. Live attenuated varicella vaccine in healthy 12- to 24-month-old children. Pediatrics 1988;81:512-8.
10. Johnson C, Rome LP, Stancin T, Kumar ML. Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pediatrics 1989;84:418-21.
11. White CJ, Kuter BJ, Hildebrand CS, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: Results from clinical trials, 1987 to 1989. Pediatrics 1991;87:604-10.
12. Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children: Final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991;9:643-7
13. Clements DA, Armstrong CB, Ursano AM, Moggio MM, Walter EB, Wilfert CM. Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents. Pediatr Infect Dis J 1995;14:874-9.
14. Johnson CE, Stancin T, Fattlar D, Rome LP, Kumar ML. A long-term prospective study of varicella vaccine in healthy children. Pediatrics 1997; 100:761-6.
15. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-11.
16. Rothstein EP, Bernstein HH, Ngai AL, Cho I, White CJ. Dose titration study of live attenuated varicella vaccine in healthy children. J Infect Dis 1997;175:444-7
17. Galil K, Watson B, Peterson C, et al. Breakthrough varicella cases since vaccine licensure in the Varicella Active Surveillance Project. Pediatr Res 2001;49:Suppl 2:150A. abstract.
18. Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993;91:17-22.
19. National, state, and urban area vaccination coverage levels among children aged 19-35 months - United States, 2000. MMWR Morb Mortal Wkly Rep 2001;50:637-41.
20. Loparev VN, Argaw T, Krause PR, Takayama M, Schmid DS. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J Clin Microbiol 2000;38:3156-60.
21. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 1992;66:1016-20.
22. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63:1055-68.
23. Fine PE, Zell ER. Outbreaks in highly vaccinated populations: Implications for studies of vaccine performance. Am J Epidemiol 1994;139:77-90.
24. Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella in the United States, 1988 to 1995. Pediatr Infect Dis J 2002;21:931-5.
25. Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: Trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000;182:383-90.